left-caret
Insights

attorney authored

Crucial Biotech Patentability Question in Myriad Case

December 14, 2010

By Gerald Flattmann

Gerald Flattmann, a partner in the intellectual property practice group, talks with Bloomberg Law's Lee Pacchia about the Myriad Genetics case and recent patent law developments that may signal a shift in the way courts view patents on human genes.